Infinium Pharmachem Limited (NSE:INFINIUM)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019
Intermediate Chemicals		1.52B	1.34B	1.14B	991.19M	547.59M
Biocall		33.25M	18.06M	-	-	-
Total		1.56B	1.36B	1.14B	991.19M	547.59M

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019
India		1.36B	1.18B	826.92M	726.35M	373.50M
Export		159.25M	175.23M	290.48M	256.62M	172.19M
SEZ		12.09M	5.62M	24.86M	8.23M	-
Unallocated		25.25M	-	-	-	-
Total		1.56B	1.36B	1.14B	991.19M	545.68M

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 21, 2026

Data Sources Report a data error